A detailed history of Times Square Capital Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Times Square Capital Management, LLC holds 684,384 shares of INSM stock, worth $55.4 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
684,384
Previous 483,869 41.44%
Holding current value
$55.4 Million
Previous $35.3 Million 33.77%
% of portfolio
0.73%
Previous 0.54%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$66.29 - $76.63 $13.3 Million - $15.4 Million
200,515 Added 41.44%
684,384 $47.2 Million
Q3 2024

Nov 04, 2024

BUY
$62.0 - $79.01 $30 Million - $38.2 Million
483,869 New
483,869 $35.3 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $11B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.